(1) The Value of Plasma Von Willebrand Factor and Soluble P-Selectin in the Early Cardiac Pacing.

(2) Objective To investigate the expression of von Willebrand factor in osteosarcoma and its association with pulmonary metastasis.

(3) Von Willebrand disease is characterized primarily by a defect in platelet adhesion to the endothelium.

(4) When the intima of a blood vessel is disrupted, as happens after a cut or the rupture of an atherosclerotic plaque, subendothelial collagen and von Willebrand factor are exposed to circulating blood.

(5) ObjectiveTo explore the changes of plasma vascular endothelial growth factor(VEGF) and von Willebrand factor(VWF) in patients with diabetic retinopathy(DR) and their significance.

(6) Objective To study the clinical significance of the changes of von willebrand factor(VWF) and D-dimer(D-D) in patients with 2-type diabetes mellitus(2-DM) and with 2-DM and essential hypertension(EH).

(7) AIM: To discuss the clinical significance of the changes of plasma D dimer and von Willebrand factor levels in patients with malignant lymphoma.

(8) When vessel walls are damaged, collagen and tissue factor are exposed, and circulating platelets adhere via von Willebrand factor and undergo a change in shape with the accompanying release of ADP.

(9) Von Willebrand disease is the most commonly inherited bleeding disorder, caused by the inheritance of a quantitative or qualitative abnormality of von Willebrand factor.

(10) These anti-coagulants are made in the liver and consequently Factor VIII and Von Willebrand factor will go up which are made in the endothelium.

(11) Plasma P - selectin , endothelin - 1 ( ET 1 ) and von willebrand factor ( vWF ) were measured.

(12) To explore the experiences of diagnosis and treatment in acquired von Willebrand disease(AVWD) caused by systemic lupus erythematosus(SLE).